Relating to authority of public and open-enrollment charter school campuses to maintain a supply of and administer anaphylaxis medicine.
Relating to rules concerning administration and maintenance of anaphylaxis medicine on public school campuses.
Relating to the administration of epinephrine medication by public and private schools.
Relating to the use of epinephrine auto-injectors on public school and open-enrollment charter school campuses and at or in transit to or from off-campus school events.
Relative to the use of nasal spray to treat anaphylaxis.
Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to immunity from liability for public and open-enrollment charter school campuses that maintain a supply of epinephrine auto-injectors for emergency use.